BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12070754)

  • 1. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.
    Ghelardini C; Galeotti N; Gualtieri F; Romanelli MN; Bucherelli C; Baldi E; Bartolini A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):419-26. PubMed ID: 12070754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
    Guandalini L; Martino MV; Di Cesare Mannelli L; Bartolucci G; Melani F; Malik R; Dei S; Floriddia E; Manetti D; Orlandi F; Teodori E; Ghelardini C; Romanelli MN
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1700-1704. PubMed ID: 25813160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
    Martini E; Norcini M; Ghelardini C; Manetti D; Dei S; Guandalini L; Melchiorre M; Pagella S; Scapecchi S; Teodori E; Romanelli MN
    Bioorg Med Chem; 2008 Dec; 16(23):10034-42. PubMed ID: 18954993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs.
    Guandalini L; Martini E; Di Cesare Mannelli L; Dei S; Manetti D; Scapecchi S; Teodori E; Ghelardini C; Romanelli MN
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1936-9. PubMed ID: 22325944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
    Scapecchi S; Martini E; Manetti D; Ghelardini C; Martelli C; Dei S; Galeotti N; Guandalini L; Novella Romanelli M; Teodori E
    Bioorg Med Chem; 2004 Jan; 12(1):71-85. PubMed ID: 14697772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.
    Martino MV; Guandalini L; Di Cesare Mannelli L; Menicatti M; Bartolucci G; Dei S; Manetti D; Teodori E; Ghelardini C; Romanelli MN
    Bioorg Med Chem; 2017 Mar; 25(6):1795-1803. PubMed ID: 28238510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
    Martini E; Salvicchi A; Ghelardini C; Manetti D; Dei S; Guandalini L; Martelli C; Melchiorre M; Cellai C; Scapecchi S; Teodori E; Romanelli MN
    Bioorg Med Chem; 2009 Nov; 17(21):7606-14. PubMed ID: 19786353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).
    Galeotti N; Ghelardini C; Pittaluga A; Pugliese AM; Bartolini A; Manetti D; Romanelli MN; Gualtieri F
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):538-45. PubMed ID: 14600801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
    Mansouri MT; Farbood Y; Naghizadeh B; Shabani S; Mirshekar MA; Sarkaki A
    Pharm Biol; 2016 Oct; 54(10):1947-53. PubMed ID: 26828763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.
    Romanelli MN; Galeotti N; Ghelardini C; Manetti D; Martini E; Gualtieri F
    CNS Drug Rev; 2006; 12(1):39-52. PubMed ID: 16834757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
    Manetti D; Ghelardini C; Bartolini A; Bellucci C; Dei S; Galeotti N; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2000 May; 43(10):1969-74. PubMed ID: 10821709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice.
    Lo AC; De Maeyer JH; Vermaercke B; Callaerts-Vegh Z; Schuurkes JA; D'Hooge R
    Neuropharmacology; 2014 Oct; 85():178-89. PubMed ID: 24863046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn.
    Kumar V; Khanna VK; Seth PK; Singh PN; Bhattacharya SK
    Phytother Res; 2002 May; 16(3):210-6. PubMed ID: 12164263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity.
    Manetti D; Ghelardini C; Bartolini A; Dei S; Galeotti N; Gualtieri F; Romanelli MN; Teodori E
    J Med Chem; 2000 Nov; 43(23):4499-507. PubMed ID: 11087574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction.
    Kumar V; Singh PN; Muruganandam AV; Bhattacharya SK
    J Ethnopharmacol; 2000 Sep; 72(1-2):119-28. PubMed ID: 10967462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The optimizing influence of melatonin on the behavioral activity of cognitive enhancers].
    Beĭer ÉV; Khazhbiev AA; Arushanian ÉB
    Eksp Klin Farmakol; 2013; 76(10):3-5. PubMed ID: 24400380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats.
    Tokita K; Inoue T; Yamazaki S; Wang F; Yamaji T; Matsuoka N; Mutoh S
    Eur J Pharmacol; 2005 Dec; 527(1-3):111-20. PubMed ID: 16325809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats.
    Pattanashetti LA; Taranalli AD; Parvatrao V; Malabade RH; Kumar D
    Indian J Pharmacol; 2017; 49(1):60-64. PubMed ID: 28458424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calotropis procera: A potential cognition enhancer in scopolamine and electroconvulsive shock-induced amnesia in rats.
    Malabade R; Taranalli AD
    Indian J Pharmacol; 2015; 47(4):419-24. PubMed ID: 26288476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ethanolic extract of the Eclipta prostrata L. ameliorates the cognitive impairment in mice induced by scopolamine.
    Jung WY; Kim H; Park HJ; Jeon SJ; Park HJ; Choi HJ; Kim NJ; Jang DS; Kim DH; Ryu JH
    J Ethnopharmacol; 2016 Aug; 190():165-73. PubMed ID: 27267831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.